2023 Spring Cure Parkinson's Research Grant
Descriptions
Opportunity link:
Opportunity type:
Sponsor:
Award amount and duration:
Eligibility
Summary
Cure Parkinson´s seeks to fund preclinical and clinical research that have the potential to cure Parkinson´s disease. “Cure” relates to therapies that can slow, stop or reverse Parkinson´s disease. Researchers worldwide are encouraged to submit proposals for pre-clinical studies and clinical trials and research projects that have the potential to be translated into the clinic in the coming five years. Key areas include stopping disease progression, restorative therapy – cell replacement, and protecting nerve cells in the brain.
Cure Parkinson’s is not restricted to clinical trial-related work and will consider funding other important promising (laboratory and non-clinical) research which has potential to lead to a cure for Parkinson’s. This can also include funding any other research supporting or accelerating clinical trials and their outcomes, including clinical trial design, research into exploratory outcome measures, cohort definition, patient stratification, genetic data collection (e.g. bio-banking of samples), flexible bridging support (extension funding) for trials running into difficulties, screening libraries with appropriate assays, carrying out epidemiological studies, novel approaches to treatment or new methods of treatment delivery. Review the full Research Strategy for more information on the types of research Cure Parkinson's funds and the organization's funding priorities.
Deadlines
Application deadlines
RSO detailed review deadline
RSO final internal review deadline
Program application deadline
Approvals
NOTE: Consult your Faculty Associate Dean (Research) (ADR) regarding Faculty-specific deadlines and submission processes.
Principal Investigators: Complete a Research Management System (RMS) record, including a copy of your complete application, and submit this for approvals in RMS.
Postdocs, students, and trainees: For fellowships and externally-sponsored research training awards or opportunities, you must complete the Research Funding Application Approval (RFAA) Trainee PDF form, and submit it, along with a complete copy of the application, to Research Services at rsotrainee@ucalgary.ca. Trainees should not use RMS at this time.
Approvals: The University of Calgary requires that all funding applications be approved prior to submission. Approval requires signatures via either RMS or the RFAA Trainee form, in the following order:
- Principal Investigator
- Department Head
- Faculty ADR/Dean
- Research Services (on behalf of the Vice-President Research)
Read the Meaning of Grant Signatures policy to understand what your approval means. Please see the agency guidelines for details about which signatures are required on your application, as it may differ from internal requirements.
Late submissions: Late submissions will only be accepted in cases of medical or family emergencies, or other exceptional circumstances. If you submit your RMS record to Research Services after the internal deadline has passed, you must secure additional approvals. Please read: Late Applications Process.
Additional Information
Contact Details
Keywords
Cure Parkinson's
Pre-clinical studies and clinical trials
International Foundations